Fusion Pharmaceuticals Inc. Operating Lease, Liability, Noncurrent
Fusion Pharmaceuticals Inc. had Operating Lease, Liability, Noncurrent of $10.57 million as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2024-05-07
- 2024-03-31: Operating Lease, Liability, Noncurrent $10.57M.
- 2023-12-31: Operating Lease, Liability, Noncurrent $11.39M.
- 2023-09-30: Operating Lease, Liability, Noncurrent $11.83M.
- 2023-06-30: Operating Lease, Liability, Noncurrent $10.77M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2024-03-31 | $10.57M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $11.39M 10-Q · filed 2024-05-07 |
| 2023-09-30 | $11.83M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $10.77M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $11.07M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $4.58M 10-K · filed 2024-03-20 |
| 2022-09-30 | $4.87M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $5.23M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $5.55M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $5.51M 10-K · filed 2023-03-16 |
| 2021-09-30 | $5.78M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $6.08M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $6.32M 10-Q · filed 2021-05-11 |